BillionaireNet
Kulkov
Egor Kulkov
Rank #974
RUSSIAHealthcarePharmaceuticals

Egor Kulkov

Net Worth
$4.142B
0% (24h)
Egor Kulkov, born in 1971, is a prominent figure in the global pharmaceutical industry, ranking among the world's billionaires. His estimated net worth is $4.1 billion as of December 16, 2025. Kulkov's wealth stems from his strategic investments and leadership in the pharmaceutical sector. He co-founded Pharmstandard, now Russia's leading pharmaceutical company, and holds significant stakes in other pharmaceutical firms, including OTCPharm, Biocad, and Generium. His career has been marked by a focus on innovation, exemplified by his early investment in CMR Surgical, a British medical technology firm. Kulkov is known for maintaining a low profile while continuing to shape the healthcare landscape.

The Full Dossier

Early Life and Education

Egor Nikolaevich Kulkov was born on December 7, 1971, in Novosibirsk, Russia. He earned a Master of Science degree from Novosibirsk State University.

Rise to Success

Kulkov's career began with a partnership with Viktor Kharitonin, co-founding the trading firm Kreditinform in 1993. They later joined Profit House, an investment company. In 1999, they entered the pharmaceutical sector by acquiring the UfaVita plant. A significant breakthrough came in 2003 when they co-founded Pharmstandard, consolidating several factories purchased from ICN Pharmaceuticals. By 2008, Kulkov and Kharitonin had bought out their partners, solidifying their control over Pharmstandard.

Key Business Strategies

Kulkov's business strategy has been characterized by strategic investments and a focus on innovation. His early investment in CMR Surgical has proven very successful, with the company's valuation growing significantly. Kulkov has also diversified his investments, including stakes in other pharmaceutical firms and the European Medical Center (EMC) in 2020. In 2023, he and Kharitonin purchased the Kama plant, diversifying into the industrial sector.

Philanthropy

Egor Kulkov is known for supporting charitable initiatives in Russia, focusing on education, healthcare, and environmental conservation. While specific philanthropy amounts are not readily available, his commitment to giving back is a noted aspect of his profile.

Career Timeline

2023

Purchased the Kama Plant

Diversified into the industrial sector.

2020

Invested in European Medical Center (EMC)

Expanded into private healthcare.

2008

Bought out partners in Pharmstandard

Solidified control over Pharmstandard.

2003

Co-founded Pharmstandard

Established Pharmstandard with partners, consolidating several factories.

1999

Acquired UfaVita plant

Entered the pharmaceutical sector.

1993

Co-founded Kreditinform

Co-founded a trading firm with Viktor Kharitonin.

Philanthropic Impact

PhilanthropyNot Available

Various Initiatives

Supports educational, healthcare, and environmental conservation initiatives in Russia.

Wealth Trajectory